Beam Therapeutics
BEAM
Verlauf der Aktienposition
Weitere Fonds mit BEAM im Portfolio
Fidelity Investments
Boston, Massachusetts
2,32 Bio. $ AUM
44,66 %
1-J.-Rendite (gesch.)
ARK Investment Management
St. Petersburg, Florida
17,4 Mrd. $ AUM
41,01 %
1-J.-Rendite (gesch.)
Farallon Capital Management
San Francisco, California
23,2 Mrd. $ AUM
69,61 %
1-J.-Rendite (gesch.)
BlackRock
New York
6,79 Bio. $ AUM
37,06 %
1-J.-Rendite (gesch.)
State Street
Boston, Massachusetts
3,44 Bio. $ AUM
36,12 %
1-J.-Rendite (gesch.)
Vanguard Portfolio Management
Malvern, Pennsylvania
2,21 Bio. $ AUM
Vanguard Capital Management
Malvern, Pennsylvania
4,76 Bio. $ AUM
Arch Venture Management
Chicago, Illinois
1,61 Mrd. $ AUM
117,07 %
1-J.-Rendite (gesch.)
Kynam Capital Management
Princeton, New Jersey
1,81 Mrd. $ AUM
89,02 %
1-J.-Rendite (gesch.)
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo, Japan
174 Mrd. $ AUM
33,96 %
1-J.-Rendite (gesch.)